Phase 2 clinical studies of SKF7™ conducted in Indonesia is the first Malaysian-led anti-obesity study to be registered on ClinicalTrials.gov, the world’s largest clinical trial database.
Medika Natura has initiated Phase 2 in-human clinical trials on its proprietary ingredient – SKF7™ – in clinics and general hospitals across Indonesia. A first for Malaysia, these clinical trials are the first Malaysian-led anti-obesity studies to be officially registered on the ClinicalTrials.gov website. These randomized double-blind placebo-controlled studies are also the first study of its kind to be conducted in Indonesia, aimed at determining the efficacy of SKF7™ in curtailing obesity, to enable it to be classified and marketed as an anti-obesity botanical drug.
ClinicalTrials.gov is run by the United States National Library of Medicine and hosts over 350,000 trials from over 200 countries.
